Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGooch & Housego Regulatory News (GHH)

Share Price Information for Gooch & Housego (GHH)

Share Price is delayed by 15 minutes
Get Live Data
1,020.00    0.00 (0.00%)
Bid:
0.00
Ask:
1,040.00
Spread: 30.00 (2.97%)
Market Cap: £279.18m
GHH Live PriceLast checked at - London Stock Exchange

Intraday Gooch & Housego Share Chart

Full Year Trading Update

5 Oct 2021 07:00

RNS Number : 9754N
Gooch & Housego PLC
05 October 2021
 

For immediate release

5 October 2021

 

 

Gooch & Housego PLC

("G&H" or the "Company")

 

Full Year Trading Update

 

"Trading slightly ahead of expectations"

Gooch & Housego PLC (AIM: GHH), the specialist manufacturer of photonic components & systems, announces that profits for the year ended 30 September 2021 are slightly ahead of management's previous expectations. The Company will announce its results for the year ended 30 September 2021 on 30 November 2021.

Trading

The Group's trading performance in the second half of the financial year has been good thanks to further strengthening in end market demand, despite currency headwinds and some supply chain constraints.

Industrial laser demand continues to be strong, in particular the semiconductor market where we have a range of growth opportunities. Life science markets are performing well. Demand for our medical diagnostics remains at previous high levels and orders for our specialist medical laser products have been strong as this market recovers from the low levels of elective surgery during the pandemic. We completed a number of significant deliveries to our aerospace and defence customers, though we do not expect commercial aerospace volumes to recover until 2023.

The streamlining of the Group's manufacturing facilities is progressing well. At the beginning of FY2021 we had 12 manufacturing sites and we now have 9. We have moved our Baltimore, Maryland production to our Boston site creating a single US fibre optic facility. In the UK we have moved our Glenrothes, Scotland and St Asaph, Wales production into Ilminster, Somerset, creating a UK precision optics hub. Our world leading optical systems engineering team has been relocated to an innovation hub in St Asaph and they remain focused on target development projects. Outsourcing of our Ilminster acousto optic production to a South East Asian manufacturer is well advanced and the final product transfers are expected to be complete over the next few months.

G&H's strong revenue performance in the second half of the financial year together with the benefits of our streamlining programme mean that Group profits are expected to be slightly ahead of management's previous expectations.

The Group delivered strong operating cashflow through the second half of the financial year and has further reduced its level of borrowings.

Outlook

 

G&H has entered its new financial year with a robust order book. As at 30 September 2021 it stood at £97.8 million (30 September 2020: £92.4 million), 5.6% higher than same period previous year, or 8.4% on a constant currency basis. The strength of the order book provides the Group with good momentum as its enters the new financial year. Industrial and medical lasers are demonstrating sustained recovery, while telecommunications and life sciences continue to perform well.

The streamlining of our manufacturing sites is on track to deliver the previously announced full year profit improvements.

We have an active development portfolio, targeted at our key growth sectors and we are working closely with many of our customers on their next generation products. There remains susbstantial long term growth potential for our photonic technologies and system capabilities in all of our target sectors. G&H is well placed to execute on acquisitions that support our strategy.

 

Mark Webster, Chief Executive Officer of Gooch and Housego, commented:

"Trading in the second half was strong, reflecting the sustained recovery in industrial and medical lasers and the robust performance of telecommunications and life sciences. Our ambitious programme to streamline our manufacturing sites is on track to deliver the previously announced full year profit improvements.

"There has been some 'drag' on performance due to currency headwinds, self isolation and supply chain issues. It is though a far better business environment than last year and we believe these factors will improve over time.

"We intend to vigoursly pursue our long term strategic goals of diversification and moving up the value chain, through internal investment and where appropriate, acquisitions."

 

 

 

For further information contact: -

 

 

 

Mark Webster/Chris Jewell

Gooch & Housego PLC

01460 256440

 

Mark Court/Sophie Wills

Buchanan

020 7466 5000

Chris Baird/David Anderson

Investec Bank plc

020 7597 5970

 

Notes to editors

1. Gooch & Housego is a photonics technology business headquartered in Ilminster, Somerset, UK with operations in the USA,Europe and China. A world leader in its field, the company researches, designs, engineers and manufactures advanced photonic systems, components and instrumentation for applications in the Aerospace & Defence, Industrial, Life Sciences and Scientific Research sectors. World leading design, development and manufacturing expertise is offered across a broad range of complementary technologies.

 

2. All financial information included in this announcement is sourced from unaudited management accounts and excludes any specific items. This announcement contains certain forward-looking statements that are based on management's current expectations or beliefs as well as assumptions about future events. These are subject to risk factors associated with, amongst other things, the economic and business circumstances occurring from time to time in the countries and sectors in which G&H operates. It is believed that the expectations reflected in these statements are reasonable but they may be affected by a wide range of variables which could cause actual results, and G&H's plans and objectives, to differ materially from those currently anticipated or implied in the forward-looking statements. Investors should not place undue reliance on any such statements. Nothing in this announcement should be construed as a profit forecast.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFSUFMLEFSELS
Date   Source Headline
3rd Jun 20267:00 amRNSDirectorate change
2nd Jun 20267:00 amRNSInterim Results
20th May 20267:00 amRNSNotice of Half Year Results
10th Apr 20262:25 pmRNSHolding(s) in Company
9th Apr 20267:00 amRNSHalf Year Trading Update
20th Mar 20263:16 pmRNSHolding(s) in Company
27th Feb 20262:23 pmRNSResult of AGM
27th Feb 20267:00 amRNSAGM Trading Update
2nd Feb 20267:00 amRNSChief Financial Officer appointment date
22nd Jan 20262:26 pmRNSHolding(s) in Company
13th Jan 20264:41 pmRNSHolding(s) in Company
12th Jan 20264:34 pmRNSPDMR notice
12th Jan 20263:30 pmRNSGrant of LTIP awards
9th Jan 20267:00 amRNSPDMR Notice and Issue of Equity
7th Jan 20267:00 amRNSPosting of Annual Report and Notice of AGM
12th Dec 20257:00 amRNSAppointment of Chief Financial Officer
2nd Dec 202511:36 amRNSDirector/PDMR Shareholding
2nd Dec 20257:00 amRNSResults for the year ended 30 September 2025
25th Nov 20257:00 amRNSNotification of Full Year Results
20th Nov 20252:14 pmRNSHolding(s) in Company
4th Nov 20257:07 amRNSDirectorate Update
8th Oct 20257:00 amRNSFurther Issue of Shares and TVR
7th Oct 20257:00 amRNSFull Year Trading Update
1st Oct 20252:15 pmRNSHolding(s) in Company
21st Jul 20257:00 amRNSChief Financial Officer Transition
15th Jul 20255:08 pmRNSHolding(s) in Company
30th Jun 20257:00 amRNSNotification of Major Holdings
23rd Jun 20252:30 pmRNSHolding(s) in Company - Replacement
20th Jun 202512:08 pmRNSHolding(s) in Company
18th Jun 20257:00 amRNSCompletion of Acquisition & Total Voting Rights
3rd Jun 20257:00 amRNSInterim Results
20th May 20257:00 amRNSNotification of Half Year Results
14th May 20257:00 amRNSAcquisition of Global Photonics
9th Apr 20252:16 pmRNSHolding(s) in Company
8th Apr 20257:00 amRNSHalf Year Trading Update
24th Feb 20252:19 pmRNSResult of AGM
24th Feb 20257:00 amRNSAGM Trading Update
7th Jan 20252:58 pmRNSGrant of LTIP Awards
6th Jan 202511:15 amRNSPosting of Annual Report and Notice of AGM
20th Dec 20243:15 pmRNSHolding(s) in Company
3rd Dec 20247:00 amRNSResults for the year ended 30 September 2024
4th Nov 20247:00 amRNSNotification of Full Year Results
30th Oct 20247:00 amRNSAcquisition of Phoenix Optical
28th Oct 20242:35 pmRNSHolding(s) in Company
8th Oct 20247:00 amRNSFull Year Trading Update
26th Sep 202410:31 amRNSDirector/PDMR Shareholding
23rd Aug 202412:52 pmRNSNotification of Major Holdings
16th Aug 20245:46 pmRNSHolding(s) in Company
16th Aug 20244:49 pmRNSHolding(s) in Company
15th Aug 20244:33 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.